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a b s t r a c t
Introduction: MRI generated forces are the source of potential complications in patients with
cardiac implantable electronic devices (CIED). The technological progress, and growing clinical
evidence concerning the operation of the contemporary MR non-conditional CIEDs during
MRI, have started to signiﬁcantly change our every-day clinical practice. Nevertheless, a lot of
patients who could have an MRI performed safely, still have been refused the examination.
State-of-the-art: In many clinical situations, an MRI examination in a patient with a CIED is
reasonable, and is linked to a negligible risk of complications if performed under strict
precautions. TheMagnaSave Registry that evaluated the inﬂuence of nonthoracicMRI on the
function of MR non-conditional CIEDs, and numerous studies involving thoracic and non-
thoracicMRIs in patientswith legacy CIEDs, have conﬁrmed the feasibility and safety of such
examinations. In this article, practical tips aimed towards improving the safety of MRI in MR
conditional and non-conditional CIED patients are largely based on the very recently
released (2017) HRS expert consensus statement.
Clinical implications: Clinical data emphasize the necessity of making the MRI more accessi-
ble to CIED patients, also in the case of MR non-conditional systems or when the thorax MR
imaging is clinically reasonable. This goal should be achieved by increasing the number of
centers complying with respective recommendations and applying protocols that would
guarantee the highest safety level.
Future directions: Further studies are warranted to assess safety issues related to the main
current contraindication to MRI, i.e., the presence of abandoned leads.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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1. Introduction
Magnetic resonance imaging (MRI) of the central nervous
system or nerve roots in patients with a cardiac implantable
electronic device (CIED) is an extremely important issue as the
inability to perform MRI may prevent diagnosing certain
neurological diseases and consequently delay or even pre-
clude adequate therapeutic decisions [1] (Fig. 1). In the aging
European population, the number of patients requiring the
implantation of devices modifying the heart activity, i.e.
pacemakers as well as implantable cardioverter deﬁbrillators
(ICDs), keeps growing [2,3] as does the number of CIED patients
referred to MRI. The Really ProMRI study, including 555 MR
conditional systems, showed that a lot of patients who could
have had an MRI safely performed, had been refused the
examination [4]. The problem concerned especially patients
with ICDs [4], although the current studies do not show any
associations between MRI-related risk and CIED type (pace-
maker vs. ICD) [5]. The principal reason for the refusal seems to
be a lack of standardized institutional investigational policies
[6] guaranteeing jointly: the appropriate cooperation between
radiologists and cardiac electrophysiologists, the assessment
of MRI advantages over the alternative imaging modalities in
respective cases, applying protocols for prescan and postscan
CIED evaluation, appropriate CIED programming during the
scan, and implementation of the effective emergency proce-
dures in the case of an adverse clinical event during the scan.
Additionally, a further convergence of appearing recommen-
dations [6,7], their extensive dissemination, and improvement
of personnel awareness are necessary to broaden the clinical
application of MR imaging in CIED patients [4].
The International Electro-technical Commission regula-
tions in force stipulate that in life-supporting equipment the
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Fig. 1 – Non-contrast MRI (A) and MRI scan after contrast administration (B) in a patient with a pacemaker and symptoms
suggestive of brachial plexus damage. MR imaging, applied because of the inconclusive CT cervical spine scan (C) and
ambiguous neurophysiological results, showed a tumour within the spine (from ‘‘Lekarz Wojskowy’’ [1], with permission
from the Publisher and Authors).
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manufactured device should be resistant to the action of the
magnetic ﬁeld. The following groups of medical devices have
been distinguished [8]: (i) MR-safe, carrying no hazard in any
MR environment; (ii) MR-unsafe, posing known hazards in all
MR environments; (iii) MR conditional and (iiii) MR non-
conditional. Cardiac implantable electronic devices have
either MR conditional status, indicating a lack of hazards in
a strictly speciﬁed MRI environment with unambiguously
deﬁned conditions of use, or non-conditional status referring
to all CIED systems other than those classiﬁed as MR
conditional [6].
The greatest hazard of an MRI examination in a CIED
patientmaybe related to thepresence of fractured, epicardial,
or abandoned endocardial or epicardial leads from a previous
system, not linked to the now-operating cardiac device. MRI
generated forces: static and gradient magnetic ﬁelds, and RF
energy, are the source of potential complications in patients
with implantable devices [9]. A static magnetic ﬁeld can lead
to a dislocation of ferromagnetic elements of a CIED. In order
to prevent the dislocation of device components, a rule of 6
weeks is applied which says that an MRI examination can be
performed no earlier than 6 weeks after the implantation.
Nevertheless, if clinically warranted, an MR scan is reason-
able in patients with recently implanted CIEDs, including MR
non-conditional systems [6]. Other potential complications
generated by the static magnetic ﬁeld are: – closure of the
reed-switch in an MR non-conditional CIED, resulting in
temporary asynchronous pacing at the pacemaker-speciﬁc
rate, and in temporary suspension of tachyarrhythmia
detection and therapy in most ICDs [9], – reversion to
power-on reset mode [9], possible at any magnetic ﬁeld
strength, wherein the oversensing the MRI-generated noise
signals in VVI mode may lead to pacing inhibition or, in a
patient with the ICD ‘‘shock-box’’ conﬁguration, to spurious
ICD tachyarrhythmia detection due to the MRI pulse-
sequence, and in consequence to triggering inappropriate
shock therapy. MRI-generated noise signals occurring due to
the high-energy electromagnetic interference, being the
result of RF energy pulses and rapidly changing magnetic
ﬁeld gradients, may be oversensed during VVI mode pacing,
and if sustained in a pacing-dependent patient, lead to
catastrophic asystole [9]. In conductive components of the
lead, a gradient magnetic ﬁeld may induce an electrical
current that,when capturedbymyocardium in the vulnerable
period of the ventricular potential, may initiate a life-
threatening ventricular tachyarrhythmia. A radiofrequency
electromagneticﬁeldmaycauseheatingof the cardiacmuscle
at or near the lead tip [10], edema of the adjacent tissues, or
even perforation. It may be manifested, among others, by
increasedpacing capture thresholds, or by loss of capture. The
risk of injury has been found to depend on the distance
between the examined body part, that is, the isocenter of the
MR scan, and a cardiac device. It raises big safety concerns for
thorax MR imaging in CIED patients. In MR conditional
pacemakers and ICDs, MR imaging procedure should comply
with manufacturer speciﬁc restrictions regarding also the
body area exclusion that depends on the devicemodel. It may
imposeno restrictions, or exclude the certainarea, i.e. fromC1
to Th12, L4, or to L5 [11]. On the other hand, numerous studies
have conﬁrmed the safety ofMRI examinationsof the thoracic
spine, chest or heart performed under the strict precautions
in MR non-conditional CIED patients [5,12].
2. State-of-the-art
In justiﬁed clinical situations, an MRI examination in a patient
with a CIED allows to give an accurate diagnosis [1], and is
linked to a negligible risk of complications when performed
under strict regulations. The landmark MagnaSave Registry
examined the inﬂuence of nonthoracic MRI examinations on
function of MR non-conditional CIEDs (1000 pacemakers and
500 ICDs), and proved its safety [13]. The prospective, single-
center study referring to unrestricted clinical practice, and to
both MR conditional and non-conditional systems, and also to
thoracic MRIs, was recently reported by Mason et al. [14]. The
primary end-points included patient's death and failure of
CIED components, and secondary end-pointswere speciﬁed as
the pacemaker/ICD battery voltage loss and predetermined
changes in intrinsic signals amplitude, pacing thresholds, and
leads impedance. The study was conducted on 178 consecu-
tive patients who had 212 MRI examinations performed (78
scans in pacing-dependent patients). It did not reveal any
malfunction of the pacemaker/ICD nor any threats to the
health and life of the patient due to MRI, regardless of MR
conditional or non-conditional status of a contemporary CIED
or examined body areas. A large prospective nonrandomized
study [12] that included 1509 patients (137 pacing-dependent),
who were implanted with MR non-conditional (legacy) CIEDs
(880 pacemakers and 629 ICDs), and underwent in total 2103
thoracic and non-thoracic MRI examinations, did not show
any clinically signiﬁcant adverse events during long-term
follow-up. It should be stressed that all MR scans in CIED
patients were performed under the strict safety regulations.
The most important event associated with MR imaging in this
study was a power-on reset that occurred in 1 in 200
examinations. In 1 case it resulted in the replacement of the
device, which was near the end of the battery life during the
examination, and afterwards could not be reprogrammed, and
in another case – in transient inhibition of pacing [12]. The very
recently published, single-center prospective cohort study of
238 MR non-conditional CIED patients, in which originally the
safety of thoracic (including 18 thoracic spine) MR scanning
was compared to non-thoracic (among others, 83 brain and 22
cervical spine) MRI, showed no adverse clinical outcomes, and
no differences concerning safety issues between the juxta-
posed groups [5]. According to the study protocol, pacing
dependent patients and those within 6 months of CIED
implantation were excluded, unless strong clinical reasons
for MRI occurred. However, the study conclusions implied
subsequent removal of these restrictions from the institution-
al electrophysiological recommendations [5].
In this article the practical tips aimed towards improving
safety of MRI both in MR conditional and in non-conditional
CIED patients are largely based on the recently released (2017)
HRS expert consensus statement [6].
The decision whether it is necessary to perform an MRI
should be discussed by a team composed of a specialist in a
respective disease-related ﬁeld, a cardiac electrophysiologist
and a radiologist. The team should ﬁrst consider the
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indications for the examination and make sure that there are
no alternative imaging diagnostic methods which might
replace MRI. What should be excluded at an early stage, is
the presence of other contraindications to an MRI examina-
tion. In the case of anuncertainCIEDhardware, a chest X-ray is
mandatory to conﬁrm absence of abandoned, fractured or
epicardial leads [5]. The information thus gathered should
serve as grounds for weighing the advantages and possible
complications which might result from the procedure.
Before the MRI it is necessary to interrogate a CIED in order
to assess: battery voltage, pacing leads thresholds, P-wave and
R-wave amplitudes, pacing impedance and where applicable
(ICD) high-voltage (shock) lead impedance, and to exclude life-
threatening arrhythmias over the past few weeks. At a pretest
capture threshold over 2.5 V at pulse width of 0.5 ms, or
battery life expectation ≤1 year (the risk of premature battery
depletion and sudden loss of therapy), MRI scanning is
contraindicated [14].
It is crucial to assess the patient in terms of pacemaker
dependence. During MRI, an MR non-conditional CIED in a
pacing-dependent patient should be programmed to an
asynchronous pacing mode. Pacing-dependent patients with
both atrial and ventricular lead should have D00 mode
selected, and those with a single chamber device – either
V00 or A00 mode. The rate of asynchronous pacing should be
determined properly to avoid competitive native rhythms, and
thus, to eliminate ventricular activation during the vulnerable-
period and initiation of ventricular tachyarrhythmias [6]. It is
also advisable to increase the stimulation amplitude to 5.0 V at
pulse width of 1.0 ms in order to avoid loss of capture during
the examination. In not pacing-dependent patients with an
MR non-conditional CIED, either a non-pacing mode (ODO/
OVO/OAO) or, at stable but slow the underlying rhythm, an
inhibited mode (DDI/VVI/AAI) is reasonable, with stimulation
and detection set to bipolar mode. In each above-mentioned
case, advanced and adaptive features should be deactivated
for scanning. Regardless of pacing-dependent status, in a
patient with an MR non-conditional ICD, anti-tachyarrhyth-
mia functions should be deactivated to avoid delivery of
unwarranted therapies [6].
Similarly, MR conditional programming before the scan
should assure the proper choice of a pacing rate and mode
(asynchronous or non-pacing), depending on patient's intrin-
sic rhythm rate and pacing dependence. Alike, in MR
conditional systems, advanced pacing algorithms should be
deactivated, and in ICDs- the tachyarrhythmia detection and
therapies disabled [6]. The manufacturer speciﬁc require-
ments for MR conditional pacemakers and ICDs should be
strictly followed.
It is recommended that the MRI examination should be
performed in the following electromagnetic ﬁeld conditions:
magnetic ﬂux density of maximum 1.5 T, a maximal electro-
magnetic energy absorption expressed in Speciﬁc Absorption
Rate (SAR) of ≤2 W/kg, and gradient magnetic ﬁeld (gradient
slew rate) ≤200 T/m/s [6]. The duration of the examination
should be as short as possible, which requires a well thought-
over choice of sequences that limits their length and number.
In general clinical practice, recommendations based on the
conclusions from the study involving, inter alia, thoracic MRIs
[14] suggested the maximal scanning time limitation to
120 min, whereas the average value of the time reached
40 min in ICD and 43 min in pacemaker patients.
The method of monitoring the patient during the MRI
examination should be predetermined, and should include: –
continuous MR conditional ECG monitoring, which may be
however associated with signiﬁcant MRI-related artifacts, –
pulse oximetry that is rather unaffected by MR scan, and –
visual and voice contact. The nursing staff trained in advanced
cardiac life support performance should be immediately
available during the examination until clinically appropriate
CIED settings are restored [6]. Other prerequisites are: – the
immediate availability of a cardiac electrophysiologist (a CIED
cardiologist) in the examination-performing center, – a
resuscitation unit in a magnetically safe area close to the
scanning location and adequately equipped with emergency
equipment, such as an external cardiac deﬁbrillator with
external pacing function, a manufacturer-speciﬁc device
programming system, or any other MR-unsafe equipment,
as well as – a readily accessible Intensive Care Unit.
After the examination, it is necessary to thoroughly assess
the CIED's status and to restore the original settings of a device
as well as to make an entry in its logbook describing the
performed procedure. Within one week after an MR scan, a
complete CIED evaluation should be repeated, and thereafter,
it should be scheduled as clinically indicated [6].
Modern CIEDs allow making MRI examinations with the
high level of safety. The most important approach was to
diminish the content of ferromagnetic elements in order to
avoid any unwanted displacement of the implant. The other
improvement consisted in the special arrangement of the
leads to decrease the voltage induced at the tips by the
radiofrequency electromagnetic ﬁeld. The essential techno-
logical change in the CIED was to replace the reed switches by
the Hall ones. More and more new products present favorable
safety proﬁles, e.g., a small-sized and leadless transcatheter
pacemaker may be placed both in 1.5 and 3 T MRI scanners
without danger to the device or a patient, and regardless of the
examined body area [15].
3. Clinical implications
Aside from the signiﬁcant technological progress, increasing
clinical data on the function of contemporary MR non-
conditional (legacy) systems in an MR environment undoubt-
edly will alter our every-day clinical practice. However, it
should be emphasized that in order to make the MRI more
accessible and also safer to CIED patients, including examina-
tions in MR non-conditional CIED subjects or a clinically
reasonable MRI of thorax, it would be crucial to increase the
number of centers complying with respective recommenda-
tions and applying protocols that will guarantee the highest
precautions during diagnostic procedures involving the
electromagnetic ﬁeld in a CIED patient.
4. Future directions
The recent study comprising CIED patients with abandoned
leads who underwent an MR imaging (80 subjects, 97 MRI
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scans, 90 abandoned leads during the scan) reported a
favorable risk-beneﬁts ratio of such a procedure [16]. Never-
theless, further studies are warranted to assess the safety
issues related to this main current contraindication to MRI.
Since Magnetic Resonance imaging at 3 T is more and more
frequently applied, in many centers being the only MR option,
MR conditional and contemporary legacy CIEDs most likely
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